Outlook Therapeutics Inc. buy BiotechBee
Start price
06.02.23
/
60%
€1.18
Target price
31.12.25
€2.00
Performance (%)
-15.64%
End price
05.05.23
€1.00
Summary
This prediction ended on 05.05.23 with a price of €1.00. The price of Outlook Therapeutics Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -15.64%. BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Outlook Therapeutics Inc. | - | - | - | - |
| iShares Core DAX® | -1,28 % | 4,21 % | 7,08 % | 64,25 % |
| iShares Nasdaq 100 | -3,34 % | -1,74 % | 26,18 % | 84,97 % |
| iShares Nikkei 225® | -4,29 % | -1,62 % | 44,32 % | 79,25 % |
| iShares S&P 500 | -2,31 % | -0,10 % | 20,82 % | 68,08 % |
According to BiotechBee what are the pros and cons of Outlook Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year